Cargando...
Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial
PURPOSE: The CRASH-3 trial is a randomised trial of tranexamic acid (TXA) on death and disability in patients with traumatic brain injury (TBI). It is based on the hypothesis that early TXA treatment can prevent deaths from post-traumatic intracranial bleeding. The results showed that timely TXA tre...
Gardado en:
| Publicado en: | Eur J Trauma Emerg Surg |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7851008/ https://ncbi.nlm.nih.gov/pubmed/32076783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00068-020-01316-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|